The importance of dual 5α-reductase inhibition in the treatment of male pattern hair loss: Results of a randomized placebo-controlled study of dutasteride versus finasteride
- 1 December 2006
- journal article
- research article
- Published by Elsevier BV in Journal of the American Academy of Dermatology
- Vol. 55 (6), 1014-1023
- https://doi.org/10.1016/j.jaad.2006.05.007
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Efficacy and Safety of Long-Term Treatment with the Dual 5α-Reductase Inhibitor Dutasteride in Men with Symptomatic Benign Prostatic HyperplasiaEuropean Urology, 2004
- Immunohistochemical localization of types 1 and 2 5α-reductase in human scalpBritish Journal of Dermatology, 1999
- Predominance of type I 5α‐reductase in apocrine sweat glands of patients with excessive or abnormal odour derived from apocrine sweat (osmidrosis)British Journal of Dermatology, 1998
- Finasteride in the treatment of men with androgenetic alopeciaJournal of the American Academy of Dermatology, 1998
- Different Levels of 5α-Reductase Type I and II, Aromatase, and Androgen Receptor in Hair Follicles of Women and Men with Androgenetic AlopeciaJournal of Investigative Dermatology, 1997
- Activity of the Type 1 5α-Reductase Exhibits Regional Differences in Isolated Sebaceous Glands and Whole SkinJournal of Investigative Dermatology, 1995
- The effect of finasteride, a 5 alpha-reductase inhibitor, on scalp skin testosterone and dihydrotestosterone concentrations in patients with male pattern baldnessJournal of Clinical Endocrinology & Metabolism, 1994
- Immunocytochemical localization of human 5 alpha-reductase 2 with polyclonal antibodies in androgen target and non-target human tissues.Journal of Histochemistry & Cytochemistry, 1994
- Steroid 5 alpha-reductase 2 deficiencyEndocrine Reviews, 1993
- Male Pattern Baldness: classification and IncidenceSouthern Medical Journal, 1975